Travelers Face Greater Risk of Leg Clots

... Known as deep vein thrombosis (DVT) or venous thromboembolism (VTE), this serious condition can sometimes lead ... Dr. Samuel Z. Goldhaber, director of the Venous thromboembolism Research Group in the cardiovascular division of ... Medical School, Boston, and director, Venous thromboembolism Research Group, cardiovascular division, Brigham ...

For Prevention of Stroke, Surveyed Cardiologists and PCPs Expect to Prescribe Xarelto to Approximately One-Third of Newly-Diagnosed Atrial Fibrillation Patients

... report entitled Novel Anticoagulants for Venous thromboembolism and Stroke Prevention in Atrial Fibrillation: ... for stroke prevention and heparins for venous thromboembolism prevention (VTE), both drug classes have ... alone. Novel Anticoagulants for Venous thromboembolism and Stroke Prevention in Atrial Fibrillation: ...

Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients

... a therapy's effect on the prevention of venous thromboembolism (VTE) is the attribute that most influences their ... the market. The new report entitled Venous thromboembolism Prophylaxis in Medically Ill Patients: ... over Lovenox." About the Report Venous thromboembolism Prophylaxis in Medically Ill Patients: ...

Research highlights new approaches to prevent blood clots

... as venous thromboembolism. "Venous thromboembolism is a serious public health problem that affects ... to that of the placebo group. Venous thromboembolism occurred 11 times in both the nadroparin and ... with idraparinux. Rates of recurrent venous thromboembolism (2.3 percent versus 3.2 percent) and fatal or ...

Transfusions increase clot risk in hospitalized cancer patients

... , pose a quandary for doctors who want to prevent thromboembolism one of the leading causes of illness and death ... those patients, 7.2 percent developed venous thromboembolism (VTE) and 5.2 percent developed arterial thromboembolism (ATE.) That's significantly higher than the 3.8 ...

Drugs used for cancer-associated anemia linked with increased risk of blood clots, death

... is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in ... that there may be a higher risk of venous thromboembolism (VTE) with these medications, but it has not been ... ESA vs. the control (placebo) group. Venous thromboembolism was evaluated for 38 trials that included 8,172 ...

In-Flight Clot Risk Low for Most People

... Medical Center, The Netherlands. Venous thromboembolism is a condition where blood clots form in the ... Harvard Medical School and director of the Venous thromboembolism Research Group at Brigham and Women's Hospital in ... "is a tiny risk compared with the risk of venous thromboembolism from obesity, severe medical illness, cancer, or ...

New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery

... therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral ... that oral, not transdermal estrogen may increase the risk of venous thromboembolism in postmenopausal women." ...

Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations

... Eisai Inc. "As the Acting Surgeon General's Call to Action on Venous thromboembolism (VTE) gets underway, we are pleased to be working with the NATF to ... hospitals enhance their efforts to prevent DVT. "Fatal Venous thromboembolism (VTE) may be the most common preventable cause of hospital death in the ...

Transfusing Anemic Cancer Patients Boosts Clot Risk

... from 1995 to 2003. Of those patients, 7.2 percent developed venous thromboembolism (VTE), and 5.2 percent developed arterial thromboembolism (ATE), compared with rates of 3.8 percent and 3.1 percent, respectively, ...

More>>

Thromboembolism in Medical Technology

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... as venous thromboembolism. "Venous thromboembolism is a serious public health problem that affects ... to that of the placebo group. Venous thromboembolism occurred 11 times in both the nadroparin and ... with idraparinux. Rates of recurrent venous thromboembolism (2.3 percent versus 3.2 percent) and fatal or ...

New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery

... therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to ... that oral, not transdermal estrogen may increase the risk of venous thromboembolism in postmenopausal women." Transdermal estrogen therapies available by ...

Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home

... physicians in achieving better outcomes for AF, venous thromboembolism patients INDIANAPOLIS, March 19 /PRNewswire/ -- Medicare Part B will now ... one-third reduction in death from all causes. The study also showed that thromboembolism was decreased by 55 percent and major hemorrhage was also decreased.(1) ...

Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)

... hospitals in an effort to improve quality and reduce costs. About Venous thromboembolism (VTE) Venous thromboembolism is a general term used to describe the formation of a blood clot ...

Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study

... and utility of genetic tests for FVL and prothrombin G20210A. This report, titled Outcomes of Genetic Testing in Adults with a History of Venous thromboembolism , is the fifth evidence report requested for EGAPP. The authors, who were led by Jodi Segal, M.D., of the AHRQ-supported Johns Hopkins ...

CRESTOR(R) Reduced Risk of Blood Clots in the Veins

... -- A new analysis from the JUPITER study shows that CRESTOR(R) (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive ...

Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation

... CV morbidity and mortality(7). The aims of treatment for patients with AF are related to managing the arrhythmia itself and to the prevention of thromboembolism (obstruction of a blood vessel caused by fragments of a blood clot carried from the site of origin to obstruct another vessel). Atrial fibrillation ...

Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b

... Congress of the European Society of Cardiology showed that the investigational oral Factor Xa inhibitor DU-176b reduced the incidence of venous thromboembolism (VTE) compared with dalteparin among patients undergoing elective unilateral hip replacement surgery. There was a statistically significant dose ...

Portola Completes $60 Million Financing to Advance Its Therapeutic Programs

... successfully completed a Phase 2 trial demonstrating betrixaban's proof of clinical concept and a favorable tolerability profile in preventing venous thromboembolism in patients undergoing knee replacement surgery. Later this year, Portola will initiate a Phase 2 clinical study in 500 patients comparing the safety ...

Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis

... nocturnal hemoglobinuria. Blood. 2005;106:3699-3709. (5) Hillmen P, Muus P, Duhrsen U et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007; 100:4123-4128. (6)Hillmen P, Young NS, Schubert J et al. The complement ...

More>>

Thromboembolism in Medical Products

Venous Thromboembolism (VTE), Qualitative

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...
Company:ARUP Laboratories

Thromboembolism in Medical Dictionary

Thromboembolism

... Pulmonary thromboembolism Dr Trisha Macnair An in-depth look at the symptoms of a pulmonary thromboembolism , when a blood clot travels to the lungs , plus ways to avoid it. thromboembolism Blockage of a blood vessel by the piece of a ...

Pulmonary

... distinct borders (well-defined) and is uniform in density. Pulmonary thromboembolism Dr Trisha Macnair An in-depth look at the symptoms of a pulmonary thromboembolism , when a blood clot travels to the lungs , plus ways to avoid it. ...

Serum sickness

... ( Thalassemia ) Thalassemia Minor ( Thalassemia ) Thromboembolic State ( thromboembolism ) thromboembolism ... ...

Sickle cell trait

... ( Thalassemia ) Thalassemia Minor ( Thalassemia ) Thromboembolic State ( thromboembolism ) thromboembolism ... ...

Platelet

... you could bleed to death . The presence of both clotting and anti -clotting agents in the blood ensures a balanced system. A platelet . thromboembolism Blockage of a blood vessel by the piece of a blood clot that has broken loose from its original site. Low platelet count ( ...

Postoperative

... As with most open surgery , surgeons are also concerned about blood clots forming in the legs and traveling to the lungs ( venous thromboembolism ), bowel problems, and postoperative pain . Classifications of Surgery Preoperative Workup Operative Procedures Benefits and Risks of ...

Splenomegaly

... Leukocyte alkaline phosphatase (>100 units in the absence of fever or infection ). Splenomegaly Abnormal enlargement of the spleen . thromboembolism A clot in the blood that forms and blocks a blood vessel. It can lead to infarction , or death of the surrounding tissue due to lack of ...

Venous

... Analgesia) device. Anticoagulant treatment , which breaks down the blood clot in the veins, is often given to patients with venous thromboembolism (VTE). More severe cases often require hospitalization and the use of stronger intra venous antibiotics . ...

More>>

Thromboembolism in Biological News

New research shows no link between aromatase inhibitors and cardiovascular problems

... the risk of breast cancer recurring. Also, we should not forget the life-threatening toxicities associated with tamoxifen therapy such as venous thromboembolism (VTE) and endometrial cancer, which do not appear to be a problem with AIs. While AIs have not demonstrated the lipid-lowering properties of ...

Thromboembolism in Biological Technology

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

... for the Evaluation of Patients at Risk for Venous thromboembolism in the Acute Hospital Care Setting) published ... in medical patient." About venous thromboembolism (VTE) Venous thromboembolism is a general term used to describe the ...

Clexane(R)/Lovenox(R) Approved in Japan

... Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing orthopaedic surgery ... replacement and hip fracture surgery. Venous thromboembolism is a frequent and preventable complication ... to greatly contribute to the prevention of venous thromboembolism and fulfil an important medical need for patients ...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay

... - Now for Exclusion of Venous thromboembolism - LEXINGTON, Mass., Oct. 9 /PRNewswire/ -- Instrumentation ... to expand the intended use for HemosIL D-Dimer HS to exclude venous thromboembolism (VTE) in outpatients suspected of deep vein thrombosis (DVT) and pulmonary ...

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

... retrieval post device implantation if desired or deemed necessary by the treating physician, and can be used in the following conditions: pulmonary thromboembolism when anticoagulant therapy is contraindicated, failure of anticoagulant therapy in thromboembolic diseases, emergency treatment following massive PE, ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

... after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism. 2002; 88:407-14. (4) Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism medical patients. CurrOpin PulmMed. 2004; 10:356-365. (5) Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ...

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

... after the date hereof, except when a duty arises under law. (1) Hillmen P, Muus P et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients. Blood. 2007;110:4123-4128) (2) Machado RF, Anthi A, Martin et al. N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of ...

Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation

... is well tolerated over a range of dose levels. Portola may develop betrixaban for additional indications including prevention of venous thromboembolism (VTE) in medically ill patients and in those undergoing major orthopedic surgery, treatment and secondary prevention of VTE, and acute coronary ...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay

... the US Food and Drug Administration (FDA) has granted 510(k) clearance to expand the intended use for the HemosIL D-Dimer assay to exclude venous thromboembolism (VTE) in outpatients suspected of deep venous thrombosis (DVT) and pulmonary embolism (PE), when used in conjunction with a clinical pretest ...

Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents

... JAMA, February 27, 2008 - Vol. 299. No. 8: 'Venous thromboembolism and Mortality Associated with Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia' ...

49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases

... of the meeting include special symposia, education programs, special interest seminars, and scientific sessions. A special symposium on venous thromboembolism will provide an overview of this common clotting disorder from the patient, public health, and scientific sectors. Guest speaker Melanie Bloom, ...

Thromboembolism in Biological Dictionary

Pulmonary veins

... the pulmonary veins can lead to violation of the pleural ... Information and resources pertaining to the pulmonary veins of the heart. ... thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) - ... Pulmonary veins stenosis information including symptoms, diagnosis, ...